[EN] 3-DIARYLMETHYLENES AND USES THEREOF<br/>[FR] 3-DIARYLMÉTHYLÈNES ET LEURS UTILISATIONS
申请人:ATUX ISKAY LLC
公开号:WO2021188949A1
公开(公告)日:2021-09-23
3-Diarylmethylenes are disclosed. The compounds activate PP2A, suppress oncogenic kinase signaling, and negatively regulate MYC and MYCN in cancer. The compounds also induce FOXO transcription factor translocation to the nucleus by modulating PP2A and, as a consequence, exhibit anti-proliferative effects. They are useful in the treatment of a variety of disorders, including as a monotherapy in cancer treatment, or used in combination with other drugs to restore sensitivity to chemotherapy where resistance has developed.
TRICYCLIC DERIVATIVES AND THEIR USE IN PHARMACEUTICALS
申请人:SCHERING CORPORATION
公开号:EP0733043A1
公开(公告)日:1996-09-25
US4116665A
申请人:——
公开号:US4116665A
公开(公告)日:1978-09-26
US5464840A
申请人:——
公开号:US5464840A
公开(公告)日:1995-11-07
[EN] TRICYCLIC DERIVATIVES AND THEIR USE IN PHARMACEUTICALS<br/>[FR] DERIVES TRICYCLIQUES ET LEUR UTILISATION DANS DES PRODUITS PHARMACEUTIQUES
申请人:SCHERING CORPORATION
公开号:WO1995015949A1
公开(公告)日:1995-06-15
(EN) Disclosed are compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof. Also disclosed are pharmaceutical compositions containing compounds of formula (I), methods for inhibiting tumor necrosis factor-$g(a) and methods for treating septic shock, inflammation, or allergic disease.(FR) L'invention se rapporte à des composés de la formule (I) ou à un sel ou un solvate pharmaceutiquement acceptables de ceux-ci. L'invention se rapporte également à des compositions pharmaceutiques contenant les composés de la formule (I), à des procédés inhibant le facteur de nécrose tumorale $g(a) et à des procédés de traitement du choc septique, des inflammations ou des maladies allergiques.